Short Communication
Babak Eliassi-Rad
Abstract
Glaucoma is one of driving reasons for irreversible loss of vision and visual impairment around the world. Glaucoma treatment is by bringing down the intraocular pressure (IOP). This includes utilizing drugs, laser, or medical procedure. Glaucoma filtration medical procedure (trabeculectomy and additionally glaucoma waste inserts) is the backbone of surgeries for glaucoma. While compelling in bringing down the IOP, the two methods are related with conceivable vision undermining entanglements. Thusly broad exploration has been done to create methodology that lessen IOP viably and are protected. Miniaturized scale obtrusive glaucoma medical procedure (MIGS) has risen for the treatment of open-edge glaucoma (essential or auxiliary). MIGS is performed by means of an abdominal muscle interno approach, with insignificant tissue interruption, in this manner a more positive hazard profile and quicker recuperation contrasted with traditional glaucoma medical procedure. It is typically joined with waterfall medical procedure and acted in patients with gentle to direct glaucoma. The current MIGS gadgets lower IOP by various systems. These include: Increasing traditional trabecular meshwork surge by means of Schlemm's trench gadget: Trabecular smaller scale sidestep shunt (iStent, Glaukos, Laguna Hills, CA, USA), Hydrus miniaturized scale stent (Ivantus, Irvine, CA, USA), or abdominal muscle interno trabeculotomy: Trabectome (NeoMedix, Tustin, CA, USA), GATT (GonioscopyAssisted Transluminal Traculomotomy), Kahook Dual Blade (New World Medical, Rancho Cucamonga, CA, USA), Trab 360 (Sight Sciences, Menlo Park, CA, USA), and ABiC (stomach muscle interno canaloplasty), (Ellex, Adelaide, Australia), Supraciliary microstenting: CyPass Micro-Stent (Alcon, Fort Worth, TX, USA) and iStent Supra (Glaukos, Laguna Hills, CA, USA). Utilization of subconjunctival space: Xen Gel Stent (Allergan,Irvine, CA, USA) and InnFocus MicroShunt (Santen, Miami, FL, USA).